Medtronic HMS PLUS Gebrauchsanweisung Seite 178

PN 86506001 Rev. 3.0
86509001_Rev2.book Page 2 Friday, November 14, 2008
Literatur
9-2 HMS Plus Gebrauchsanweisung
9:46 AM
Adkins JR, Hardy JD. Sodium heparin neutralization and the anticoagulant
effects of protamine sulfate. Arch Surg. 1967;94:175.
Allen G, Freeman DJ. Heparin assay and protamine titration. Am J Clin Pathol.
1981;76:410.
Allen TH. Prediction of blood volume and adiposity in man from body weight
and cube of height. Metabolism. 1956;5:328.
Baugh RF. Detection of whole blood coagulation. Am Clin Prod Rev. 1984 (Nov).
Bowie JE, Kemna GD. Automated management of heparin anticoagulation in
cardiovascular surgery. Proc Am Acad Cardiovasc Perfus. 1985;6:84.
Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during
extracorporeal circulation. Problems inherent in existing heparin protocols. J
Thorac Cardiovasc Surg. 1975;69(I):764.
Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during
extracorporeal circulation. The use of a dose response curve to individualize
heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69(II):684.
Cloyd GM, D'Ambra MN, Akins CW. Diminished anticoagulant response to
heparin in patients undergoing coronary artery bypass grafting. J Thorac
Cardiovasc Surg. 1987;94:535.
Cohen EJ, Camerlengo LJ, Dearing J. Activated clotting times and
cardiopulmonary bypass. The effect of hemodilution and hypothermia upon
activated clotting time. J Extracorp Tech. 1980;12:139.
Chargaff E, Olson KB. Studies on the chemistry of blood coagulation. Studies
on the action of heparin and other anticoagulants. The influence of protamine
on the anticoagulant effect in vivo. J Biol Chem. 1937;122:153.
Codispoti M, Rowney D, Young C, Mankad PS. Individualized and precise
control of heparin concentration and neutralization reduces thrombin
formation, blood loss and transfusions in paediatric patients undergoing open
heart surgery. 19th Annual Cardiothoracic Surgery Symposium:
Pathophysiology and Techniques of Cardiopulmonary Bypass. San Diego,
Calif. 1999.
Culliford AT, Geital SN, Starr N, et al. Lack of correlation between activated
clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg.
1981;193:105.
D'Errico C, Shayevitz JR, Martindale SJ. Age-related differences in heparin
sensitivity and heparin-protamine interactions in cardiac surgery patients. J
Cardiothorac Vasc Anesth. 1996;10:451.
Despotis GJ, Summerfield AL, Joist JH, et al. Comparison of activated
coagulation time and whole blood heparin measurements to laboratory
plasma anti-Xa heparin concentration in cardiac surgical patients. J Thorac
Cardiovasc Surg. 1994;104:1076.
1 Part# 86509001 Rev 2.0